Trial · NCT02408549
Adverse events85
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 85
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vertigo | Ear and labyrinth disorders | All Participants (Lacosamide) | 19 | 239 | 30 |
| other | Diplopia | Eye disorders | All Participants (Lacosamide) | 12 | 239 | 15 |
| other | Nausea | Gastrointestinal disorders | All Participants (Lacosamide) | 23 | 239 | 31 |
| other | Diarrhoea | Gastrointestinal disorders | All Participants (Lacosamide) | 18 | 239 | 23 |
| other | Vomiting | Gastrointestinal disorders | All Participants (Lacosamide) | 16 | 239 | 24 |
| other | Fatigue | General disorders | All Participants (Lacosamide) | 13 | 239 | 15 |
| other | Pyrexia | General disorders | All Participants (Lacosamide) | 13 | 239 | 13 |
| other | Nasopharyngitis | Infections and infestations | All Participants (Lacosamide) | 52 | 239 | 91 |
| other | Influenza | Infections and infestations | All Participants (Lacosamide) | 18 | 239 | 23 |
| other | Upper respiratory tract infection | Infections and infestations | All Participants (Lacosamide) | 17 | 239 | 18 |
| other | Corona virus infection | Infections and infestations | All Participants (Lacosamide) | 14 | 239 | 16 |
| other | Contusion | Injury, poisoning and procedural complications | All Participants (Lacosamide) | 24 | 239 | 30 |
| other | Laceration | Injury, poisoning and procedural complications | All Participants (Lacosamide) | 12 | 239 | 14 |
| other | Back pain | Musculoskeletal and connective tissue disorders | All Participants (Lacosamide) | 17 | 239 | 19 |
| other | Headache | Nervous system disorders | All Participants (Lacosamide) | 56 | 239 | 113 |
| other | Dizziness | Nervous system disorders | All Participants (Lacosamide) | 53 | 239 | 73 |
| other | Somnolence | Nervous system disorders | All Participants (Lacosamide) | 40 | 239 | 51 |
| other | Grand mal convulsion | Nervous system disorders | All Participants (Lacosamide) | 14 | 239 | 16 |
| other | Migraine | Nervous system disorders | All Participants (Lacosamide) | 13 | 239 | 17 |
| serious | Cardiac failure | Cardiac disorders | All Participants (Lacosamide) | 1 | 239 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02408549/events